Yamashita et al. [15] reported that both EpCAM and CD133 may be hepatic cancer stem cell markers specifically in HpSC-HCC; however, very few reports have investigated the cancer stem cell marker in CLC. Here, EPCAM is linked to hepatocellular carcinoma.